Portrait of Dr. Chet Tharpe

Medical Director Β· Curex

Dr. Chet TharpeMD

Allergy and Immunology Β· 15+ years in practice

years in practice
15+years in practice
board certifications
2board certifications
peer-reviewed studies
2peer-reviewed studies
pages reviewed
18pages reviewed

Biography

Dr. Chet Tharpe serves as Medical Director at Curex, where he oversees clinical protocols for sublingual immunotherapy and reviews patient treatment plans. He has spent more than 15 years treating allergic rhinitis, asthma, and environmental sensitivities, and is a published voice in the field of at-home allergen immunotherapy. In 2026 he co-authored a peer-reviewed real-world study in Frontiers in Allergy analyzing outcomes of telemedicine-delivered sublingual immunotherapy across 2,897 patients. Dr. Tharpe is a member of the American Academy of Allergy, Asthma & Immunology (AAAAI) and the American College of Allergy, Asthma & Immunology (ACAAI).

Published research

2 peer-reviewed publications, indexed in PubMed.

Peer-reviewed research Β· authored

Real-world outcomes of personalized sublingual immunotherapy for environmental allergies delivered through a telemedicine platform: a retrospective longitudinal cohort study

Frontiers in Allergy Β· 2026

Clinical content reviewed

Dr. Chet Tharpe reviewed the clinical content on 18 guides. A sample:

Ready to treat your allergies at the source?

Take the free allergy quiz to find out if immunotherapy is right for you and get started with personalized treatment today.

Take Free Allergy Quiz